Analystreport

Sutro Biopharma, Inc. (NASDAQ: STRO) had its price target lowered by analysts at Piper Sandler from $29.00 to $14.00.

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report